What is MIDI?
MIDI, Inc. is a veteran-owned biotechnology company recognized for its expertise in complex chromatographic data analysis and pattern recognition. Its proprietary Sherlock software is a key tool used globally for identifying bacteria, microbial communities, and analyzing complex matrices such as edible oils and fire debris. The company provides a comprehensive suite of solutions, including microbial identification systems and contract laboratory services for bacterial and fungal identification, primarily serving research institutions and public health laboratories with rapid, cost-effective analysis tools.
How much funding has MIDI raised?
MIDI has raised a total of $297K across 2 funding rounds:
Debt
$150K
Debt
$147K
Debt (2020): $150K with participation from PPP
Debt (2021): $147K led by PPP
Key Investors in MIDI
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for MIDI?
The substantial capital infusion, particularly the recent strategic investment, positions MIDI for accelerated growth and market penetration. As a company operating in the late-stage funding environment, this financing is likely earmarked for scaling operations, enhancing its Sherlock software capabilities, and potentially expanding its service offerings to new sectors or geographical markets. The focus on data analysis and pattern recognition in biotechnology suggests potential applications in areas such as drug discovery, diagnostics, and advanced environmental monitoring, indicating a robust future development path.
See full MIDI company page
